PMHNP - St. Louis( Greenbrook)
careers-neuronetics
| Company | careers-neuronetics |
| Category | Healthcare |
| Location | St. Louis, MO |
| Remote | — |
| Employment | Not stated |
| Level | Mid |
| Salary | Not stated by the employer |
| First seen | 4 Aug 2026 (the employer did not state a posting date) |
| Last verified | 12 Aug 2026 |
| Source | Employer ATS (rippling) |
Description
Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Nurse Practitioner to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in ST. Louis, MO.
Why Join Us?
• Flexible Part-Time schedule
• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders
Qualifications
• Psychiatric Mental Health Nurse Practitioner
• Board Certified or Board Eligible
• Active Missouri medical license (or ability to obtain)
• DEA registration (or ability to obtain)
About Greenbrook
As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients . Our mission is to transform mental health care and improve lives through innovative solutions.
Depression affects more than 16 million Americans . At Greenbrook, we’re changing the way it’s treated—and you can be part of that change.
Learn more:
• https://youtu.be/yrr-wlFftT0
• https://www.greenbrooktms.com/patient-stories
• https://www.greenbrookproviders.com
GBSP25
About Us
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.